These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 21763392)

  • 1. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].
    de Die-Smulders CE; Faber CG; Smeets HJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2043-6. PubMed ID: 16184945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on gene therapy in myotonic dystrophy type 1.
    Magaña JJ; Cisneros B
    J Neurosci Res; 2011 Mar; 89(3):275-85. PubMed ID: 21259315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-mediated neuromuscular disorders.
    Ranum LP; Cooper TA
    Annu Rev Neurosci; 2006; 29():259-77. PubMed ID: 16776586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
    Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
    Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila.
    Houseley JM; Wang Z; Brock GJ; Soloway J; Artero R; Perez-Alonso M; O'Dell KM; Monckton DG
    Hum Mol Genet; 2005 Mar; 14(6):873-83. PubMed ID: 15703191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
    Jiang H; Mankodi A; Swanson MS; Moxley RT; Thornton CA
    Hum Mol Genet; 2004 Dec; 13(24):3079-88. PubMed ID: 15496431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear RNA foci in the heart in myotonic dystrophy.
    Mankodi A; Lin X; Blaxall BC; Swanson MS; Thornton CA
    Circ Res; 2005 Nov; 97(11):1152-5. PubMed ID: 16254211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic RNA repeats: an expanding role in genetic disease.
    Ranum LP; Day JW
    Trends Genet; 2004 Oct; 20(10):506-12. PubMed ID: 15363905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic mechanisms of myotonic dystrophy.
    Lee JE; Cooper TA
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myotonic dystrophy].
    Nanba E
    Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.